AYTU BIOPHARMA, INC Capital Expenditures
AYTU BIOPHARMA, INC (AYTU) reported Capital Expenditures of $29.00 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-22.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-09-22
- AYTU BIOPHARMA, INC payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $12.00K, a 29.41% decline year-over-year.
- AYTU BIOPHARMA, INC payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- AYTU BIOPHARMA, INC payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $17.00K, a 183.33% increase year-over-year.
- AYTU BIOPHARMA, INC payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- AYTU BIOPHARMA, INC payments to acquire property, plant, and equipment for fiscal 2026 was $29.00K, a 87.28% decline from fiscal 2025.
- AYTU BIOPHARMA, INC payments to acquire property, plant, and equipment for fiscal 2025 was $228.00K, a 30.70% decline from fiscal 2024.
- AYTU BIOPHARMA, INC payments to acquire property, plant, and equipment for fiscal 2024 was $329.00K.
- AYTU BIOPHARMA, INC payments to acquire property, plant, and equipment for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 6 month as first filed | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 9 month as first filed | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 81 month | Payments to Acquire Property, Plant, and Equipment 84 month | Payments to Acquire Property, Plant, and Equipment 87 month | Payments to Acquire Property, Plant, and Equipment 90 month | Payments to Acquire Property, Plant, and Equipment 93 month | Payments to Acquire Property, Plant, and Equipment 96 month | Payments to Acquire Property, Plant, and Equipment 99 month | Payments to Acquire Property, Plant, and Equipment 102 month | Payments to Acquire Property, Plant, and Equipment 105 month | Payments to Acquire Property, Plant, and Equipment 108 month | Payments to Acquire Property, Plant, and Equipment 111 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-22 | $12.00K derived: sum of 2 quarters · filed 2026-09-22 | $29.00K derived: sum of 3 quarters · filed 2026-09-22 | $29.00K 10-K · filed 2026-09-22 | |||||||||||||
| 2026-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | $17.00K derived: sum of 2 quarters · filed 2026-05-13 | $17.00K 10-Q · filed 2026-05-13 | $34.00K derived: sum of 4 quarters · filed 2026-09-22 | |||||||||||||
| 2025-12-31 | $17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-03 | $17.00K 10-Q · filed 2026-02-03 | $34.00K derived: sum of 3 quarters · filed 2026-09-22 | $103.00K derived: sum of 4 quarters · filed 2026-09-22 | |||||||||||||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-13 | $17.00K derived: sum of 2 quarters · filed 2026-09-22 | $86.00K derived: sum of 3 quarters · filed 2026-09-22 | $92.00K derived: sum of 4 quarters · filed 2026-09-22 | |||||||||||||
| 2025-06-30 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-22 | $86.00K derived: sum of 2 quarters · filed 2026-09-22 | $92.00K derived: sum of 3 quarters · filed 2026-09-22 | $228.00K 10-K · filed 2026-09-22 | |||||||||||||
| 2025-03-31 | $69.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | $75.00K derived: sum of 2 quarters · filed 2026-05-13 | $211.00K 10-Q · filed 2026-05-13 | ||||||||||||||
| 2024-12-31 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-03 | $142.00K 10-Q · filed 2026-02-03 | |||||||||||||||
| 2024-09-30 | $136.00K 10-Q · filed 2025-11-13 | ||||||||||||||||
| 2024-06-30 | $329.00K 10-K · filed 2025-09-23 | ||||||||||||||||
| 2021-03-31 | $15.40M 10-Q · filed 2021-05-17 | ||||||||||||||||
| 2020-06-30 | -$5.85M derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-06 | -$4.50M derived: sum of 2 quarters · filed 2021-05-17 | $0.00 derived: sum of 3 quarters · filed 2021-05-17 | $0.00 10-K · filed 2020-10-06 | |||||||||||||
| 2020-03-31 | $1.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-17 | $5.85M derived: sum of 2 quarters · filed 2021-05-17 | $5.85M 10-Q · filed 2021-05-17 | $0.00 10-Q · filed 2020-05-15 | $5.85M derived: sum of 4 quarters · filed 2021-05-17 | ||||||||||||
| 2019-12-31 | $4.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-11 | $4.50M 10-Q · filed 2021-02-11 | $0.00 10-Q · filed 2020-02-14 | $4.50M derived: sum of 3 quarters · filed 2021-02-11 | $4.55M derived: sum of 4 quarters · filed 2021-02-11 | ||||||||||||
| 2019-09-30 | $0.00 10-Q · filed 2019-11-14 | $0.00 derived: sum of 2 quarters · filed 2020-10-06 | $46.89K derived: sum of 3 quarters · filed 2020-10-06 | $53.78K derived: sum of 4 quarters · filed 2020-10-06 | |||||||||||||
| 2019-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-06 | $46.89K derived: sum of 2 quarters · filed 2020-10-06 | $53.78K derived: sum of 3 quarters · filed 2020-10-06 | $59.85K 10-K · filed 2020-10-06 | |||||||||||||
| 2019-03-31 | $46.89K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-15 | $53.78K derived: sum of 2 quarters · filed 2020-05-15 | $59.85K 10-Q · filed 2020-05-15 | $59.85K derived: sum of 4 quarters · filed 2020-05-15 | |||||||||||||
| 2018-12-31 | $6.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-14 | $12.95K 10-Q · filed 2020-02-14 | $12.95K derived: sum of 3 quarters · filed 2020-02-14 | $75.47K derived: sum of 4 quarters · filed 2020-02-14 | |||||||||||||
| 2018-09-30 | $6.07K 10-Q · filed 2019-11-14 | $6.07K derived: sum of 2 quarters · filed 2019-11-14 | $68.58K derived: sum of 3 quarters · filed 2019-11-14 | ||||||||||||||
| 2018-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-26 | $62.51K derived: sum of 2 quarters · filed 2019-09-26 | $74.71K 10-K · filed 2019-09-26 | ||||||||||||||
| 2018-03-31 | $62.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-14 | $74.71K 10-Q · filed 2019-05-14 | |||||||||||||||
| 2017-12-31 | $12.20K 10-Q · filed 2019-05-14 | ||||||||||||||||
| 2017-06-30 | $58.17K derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-06 | $66.73K derived: sum of 2 quarters · filed 2018-09-06 | $106.89K derived: sum of 3 quarters · filed 2018-09-06 | $111.61K 10-K · filed 2018-09-06 | |||||||||||||
| 2017-03-31 | $8.56K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-14 | $48.71K derived: sum of 2 quarters · filed 2018-05-14 | $53.44K 10-Q · filed 2018-05-14 | $102.79K derived: sum of 4 quarters · filed 2018-05-14 | |||||||||||||
| 2016-12-31 | $40.16K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-08 | $44.88K 10-Q · filed 2018-02-08 | $94.23K derived: sum of 3 quarters · filed 2018-02-08 | $172.65K derived: sum of 4 quarters · filed 2018-02-08 | |||||||||||||
| 2016-09-30 | $4.72K 10-Q · filed 2017-11-09 | $54.08K derived: sum of 2 quarters · filed 2017-11-09 | $132.49K derived: sum of 3 quarters · filed 2017-11-09 | $254.10K derived: sum of 4 quarters · filed 2017-11-09 | |||||||||||||
| 2016-06-30 | $49.35K derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-31 | $127.77K derived: sum of 2 quarters · filed 2017-08-31 | $249.38K derived: sum of 3 quarters · filed 2017-08-31 | $252.93K 10-K · filed 2017-08-31 | |||||||||||||
| 2016-03-31 | $78.42K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-11 | $200.02K derived: sum of 2 quarters · filed 2017-05-11 | $203.58K 10-Q · filed 2017-05-11 | $203.58K derived: sum of 4 quarters · filed 2017-05-11 | |||||||||||||
| 2015-12-31 | $121.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-09 | $125.16K 10-Q · filed 2017-02-09 | $125.16K derived: sum of 3 quarters · filed 2017-02-09 | $125.16K derived: sum of 4 quarters · filed 2017-02-09 | |||||||||||||
| 2015-09-30 | $3.55K 10-Q · filed 2016-11-07 | $3.55K derived: sum of 2 quarters · filed 2016-11-07 | $3.55K derived: sum of 3 quarters · filed 2016-11-07 | ||||||||||||||
| 2015-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-01 | $0.00 derived: sum of 2 quarters · filed 2016-09-01 | $0.00 10-K · filed 2016-09-01 | ||||||||||||||
| 2015-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-11 | $0.00 10-Q · filed 2016-05-11 | |||||||||||||||
| 2014-12-31 | $0.00 10-Q · filed 2016-02-11 | ||||||||||||||||
| 2014-06-30 | $9.30K 10-K · filed 2015-09-28 | ||||||||||||||||
| 2014-05-31 | $0.00 derived: 10-Q 111 month − 10-Q 108 month · filed 2014-07-10 | $0.00 derived: sum of 2 quarters · filed 2014-07-10 | $0.00 derived: sum of 3 quarters · filed 2014-07-10 | $0.00 derived: sum of 4 quarters · filed 2014-11-26 | $26.87K 10-Q · filed 2014-07-10 | ||||||||||||
| 2014-02-28 | $0.00 derived: 10-Q 108 month − 10-Q 105 month · filed 2014-04-11 | $0.00 derived: sum of 2 quarters · filed 2014-04-11 | $0.00 derived: sum of 3 quarters · filed 2014-11-26 | $0.00 derived: sum of 4 quarters · filed 2014-11-26 | $26.87K 10-Q · filed 2014-04-11 | ||||||||||||
| 2013-11-30 | $0.00 derived: 10-Q 105 month − 10-K 102 month · filed 2014-01-10 | $0.00 derived: sum of 2 quarters · filed 2014-11-26 | $0.00 derived: sum of 3 quarters · filed 2014-11-26 | $0.00 derived: sum of 4 quarters · filed 2014-11-26 | $26.87K 10-Q · filed 2014-01-10 | ||||||||||||
| 2013-08-31 | $0.00 derived: 10-K 102 month − 10-Q 99 month · filed 2014-11-26 | $0.00 derived: sum of 2 quarters · filed 2014-11-26 | $0.00 derived: sum of 3 quarters · filed 2014-11-26 | $0.00 derived: sum of 4 quarters · filed 2014-11-26 | $26.87K 10-K · filed 2014-11-26 | ||||||||||||
| 2013-05-31 | $0.00 derived: 10-Q 99 month − 10-Q 96 month · filed 2013-06-28 | $0.00 derived: sum of 2 quarters · filed 2013-06-28 | $0.00 derived: sum of 3 quarters · filed 2013-06-28 | $0.00 derived: sum of 4 quarters · filed 2013-06-28 | $26.87K 10-Q · filed 2013-06-28 | ||||||||||||
| 2013-02-28 | $0.00 derived: 10-Q 96 month − 10-Q 93 month · filed 2013-04-15 | $0.00 derived: sum of 2 quarters · filed 2013-04-15 | $0.00 derived: sum of 3 quarters · filed 2013-04-15 | $0.00 derived: sum of 4 quarters · filed 2013-04-15 | $26.87K 10-Q · filed 2013-04-15 | ||||||||||||
| 2012-11-30 | $0.00 derived: 10-Q 93 month − 10-K 90 month · filed 2013-01-14 | $0.00 derived: sum of 2 quarters · filed 2013-01-14 | $0.00 derived: sum of 3 quarters · filed 2013-01-14 | $53.74K derived: sum of 4 quarters · filed 2013-01-14 | $26.87K 10-Q · filed 2013-01-14 | ||||||||||||
| 2012-08-31 | $0.00 derived: 10-K 90 month − 10-Q 87 month · filed 2012-11-29 | $0.00 derived: sum of 2 quarters · filed 2012-11-29 | $53.74K derived: sum of 3 quarters · filed 2012-11-29 | $53.74K derived: sum of 4 quarters · filed 2012-11-29 | $26.87K 10-K · filed 2012-11-29 | ||||||||||||
| 2012-05-31 | $0.00 derived: 10-Q 87 month − 10-Q 84 month · filed 2012-06-26 | $53.74K derived: sum of 2 quarters · filed 2012-06-26 | $53.74K derived: sum of 3 quarters · filed 2012-06-26 | $26.87K 10-Q · filed 2012-06-26 | |||||||||||||
| 2012-02-29 | $53.74K derived: 10-Q 84 month − 10-Q 81 month · filed 2012-04-12 | $53.74K derived: sum of 2 quarters · filed 2012-04-12 | $26.87K 10-Q · filed 2012-04-12 | ||||||||||||||
| 2011-11-30 | $0.00 10-Q · filed 2011-12-23 | -$26.87K 10-Q · filed 2011-12-23 | |||||||||||||||
| 2010-11-30 | $0.00 10-Q · filed 2011-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |